B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4

Immunity

Volumn 2, Issue 5, 1995, Pages 523-532

  Freeman, Gordon J ^a   Boussiotis, Vassiliki A ^a   Anumanthan, Anukanth ^a   Bernstein, Gregory M ^a   Ke, Xiao Yen ^a   Rennert, Paul D ^b   Gray, Gary S ^b   Grlbben, John G ^a   Nadler, Lee M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b REPLIGEN CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CELL RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 4; MONOCLONAL ANTIBODY;

ARTICLE; CELL DIFFERENTIATION; CELLULAR IMMUNITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

3T3 CELLS; ANIMAL; ANTIGENS, CD45; ANTIGENS, CD80; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; CHO CELLS; GENE EXPRESSION; HAMSTERS; HUMAN; IMMUNOPHENOTYPING; IN VITRO; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; LYMPHOCYTE CULTURE TEST, MIXED; LYMPHOTOXIN; MEMBRANE GLYCOPROTEINS; MICE; RECEPTORS, INTERLEUKIN-2; RNA, MESSENGER; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTE SUBSETS; TRANSFECTION;

EID: 0029073050     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/1074-7613(95)90032-2     Document Type: Article

References (61)

1. B70 antigen is a second ligand for CTLA-4 and CD28
2. Constitutive expression of B7 restores immunogenicity of autologous tumor cells
3. B7 but not ICAM-1 costimulation prevents the induction of human alloantigen specific tolerance
4. Activated human B lymphocytes express three CTLA4 binding counter-receptors which costimulate T cell activation
5. CD2 is involved in maintenance and reversal of human alloantigen specific clonal energy
6. Tumor necrosis factor a is an autocrine growth factor for normal human B cells
7. B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells
8. Prolonged IL-2 receptor alpha/CD25 expression after T cell activation via the adhesion molecules CD2 and CD28: demonstration of combined transcriptional and post-transcriptional regulation
9. CD28 costimulation up-regulates long-term IL-2Rβ expression in human T cells through combined transcriptional and posttranscriptional regulation
10. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecule CD28 and CTLA-4
11. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
12. Differential effects of blockade of CD28-87 on the development of Th1 or Th2 effector cells in experimental Leishmaniasis
13. 2+ CD45RO memory T lymphocytes
14. Immunoglobulin isotype regulation by antigen-presenting cells in vivo
15. + T cells. I. Influence of antigen concentration and antigen-presenting cell type
16. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression
17. Differentiation of T cell lymphokine gene expression: the in vitro acquisition of T cell memory
18. The B7-2 (B70) costimulatory molecule of monocytes and activated B lymphocytes is the CD86 differentiation antigen
19. IL-10 acts on the antigenpresenting cell to inhibit cytokine production by Th1 cells
20. B7, a B cell restricted antigen which identifies preactivated B cells
21. Selective induction of B7/BB-1 on interferon-γ stimulated monocytes: a potential mechanism for amplification of T cell activation
22. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells
23. Murine B7-2: an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin-2 production
24. Cloning of B7-2: a CTLA4 counter-receptor that costimulates human T cell proliferation
25. B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2
26. Human T-cell clonal energy is induced by antigen presentation in the absence of B7 costimulation
27. Cloning of human alloreactive T cells
28. B7/BB-1 is a leucocyte differentiation antigen on human dendritic cells induced by activation
29. Comparative analysis of B7-1 and 87-2 costimulatory ligands: expression and function
30. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an αβ T-cell-receptor transgenic system
31. + T cells through IL-12 produced by Listeria-induced macrophages
32. Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells
33. B7-1 and 87-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy
34. Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells
35. Generation of interleukin 4 (IL-4) producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells
36. Differential upregulation of the B7-1 and B7-2 costimulatory molecules following immunoglobulin receptor engagement by antigen
37. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors
38. CTLA-4 ligands are required to induce an in vivo interleukin 4 response to a gastrointestinal nematode parasite
39. Low affinity interaction of peptide-MHC complexes with T cell receptors
40. Role of 87-1 in mediating an immune response to myeloid leukemia cells
41. + T lymphocytes from TCR transgenic mice
42. Soluble CTLA-4 can suppress autcantibody production and elicit long term responsiveness in a novel transgenic model
43. + T cell subsets
44. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties
45. B7 and interleukin 12 cooperate for proliferation and interferon y production by mouse T helper clones that are unresponsive to B7 costimulation
46. IL-2 receptor γ chain expression on resting and activated lymphoid cells
47. A novel monoclonal antibody (FUN-1) identifies an activation antigen in cells of the B-cell lineage and Reed-Sternberg cells
48. ras
49. IL-12 inhibits Th2 cytokine responses induced by eggs of Schistosome mansoni
50. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo
51. Murine B7 antigen provides an efficient costimulatory signal for activation of murine T lymphocytes via the T-cell receptor/CD3 complex
52. Interleukin-2 receptor y chain: a functional component of interleukin-4 receptor
53. Activation and differentiation requirements of primary T cells in vitro
54. + T cells
55. The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4' T cells from T cell receptor transgenic mice
56. PCR MIMICS: competitive DNA fragments for use as internal standards in quantitative PCR
57. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigenpresenting cells
58. IL-4 directs the development of Th2-like helper effectors
59. + T cells by 87-transfected melanoma cells
60. Interleukin (IL)-4 production by human T cells: differential regulation of IL-4 vs. IL-2 production
61. Development of human Thl and Th2 cytokine responses: the cytokine production profile of T cells is dictated by the primary in vitro stimulus